Page last updated: 2024-08-24

ibandronic acid and Diabetes Mellitus, Type 2

ibandronic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Baek, KH; Kang, MI; Kim, J; Kim, KM; Lim, S; Min, YK1
Bao, X; Gao, L; Li, Y; Liu, C; Tian, Y; Wang, K1

Trials

1 trial(s) available for ibandronic acid and Diabetes Mellitus, Type 2

ArticleYear
Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.
    BMC endocrine disorders, 2022, Apr-11, Volume: 22, Issue:1

    Topics: Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diphosphonates; Female; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome

2022

Other Studies

1 other study(ies) available for ibandronic acid and Diabetes Mellitus, Type 2

ArticleYear
Denosumab Improves Glycaemic Parameters in Postmenopausal Osteoporosis Patients with Combined Type 2 Diabetes Mellitus.
    Cellular and molecular biology (Noisy-le-Grand, France), 2023, Aug-31, Volume: 69, Issue:8

    Topics: Denosumab; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Glucose; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Transcription Factors

2023